Home › NDC Lookup › RxCUI directory › RxCUI 197737

Glyburide 1.25 MG Oral Tablet — RxCUI 197737

RxNorm drug concept · Semantic clinical drug
RxCUI 197737 Semantic clinical drug · SCD ● Current RxNorm concept 27 FDA products 82 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI197737
Official nameGlyburide 1.25 MG Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asglibenclamide 1.25 MG Oral Tablet
FDA products mapped27
Package NDCs mapped82
Reported Medicaid activity (SDUD)88,877 prescriptions · 48 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Glyburide: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Great question. Diet and exercise are the foundation of managing type 2 diabetes, but sometimes they aren't enough on their own. Glyburide gives your pancreas a nudge to release mo...
  • What exactly does glyburide do — and why do I need it if I'm already watching my diet?
  • Low blood sugar — called hypoglycemia — is the main risk with glyburide. Watch for shakiness, sweating, sudden hunger, dizziness, confusion, or a fast heartbeat. If you catch it ea...
  • How do I know if my blood sugar is going too low, and what should I do?
📖 Read our full Glyburide guide →

🕸️ Concept Web — How Glyburide 1.25 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Glyburide 1.25 MG Oral Tablet RxCUI 197737

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Glyburide 4815
  2. Dose forms 6

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Glyburide Oral Tablet 372333
    • Glyburide Oral Product 1156200
    • Glyburide Pill 1156201
    • Oral Tablet 317541
    • Oral Product 1151131
    • Pill 1151133
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Glyburide 1.25 MG 315987

Showing up to 8 concepts per family — 8 of 8 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Glyburide 1.25 MG SCDC · 315987
  • Glyburide Oral Tablet SCDF · 372333
  • Glyburide Oral Product SCDG · 1156200
  • Glyburide Pill SCDG · 1156201

📦 FDA Products & Package NDCs

27 products · 82 package NDCs
82 package NDCs map to RxCUI 197737 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00093-8342-01 100 TABLET in 1 BOTTLE (0093-8342-01) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8343-01 100 TABLET in 1 BOTTLE (0093-8343-01) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8343-05 500 TABLET in 1 BOTTLE (0093-8343-05) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8343-10 1000 TABLET in 1 BOTTLE (0093-8343-10) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8343-98 90 TABLET in 1 BOTTLE (0093-8343-98) Glyburide Teva Pharmaceuticals USA, Inc. 2010-03-30
00093-8344-01 100 TABLET in 1 BOTTLE (0093-8344-01) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8344-05 500 TABLET in 1 BOTTLE (0093-8344-05) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8344-10 1000 TABLET in 1 BOTTLE (0093-8344-10) Glyburide Teva Pharmaceuticals USA, Inc. 1995-08-30
00093-8344-98 90 TABLET in 1 BOTTLE (0093-8344-98) Glyburide Teva Pharmaceuticals USA, Inc. 2010-03-30
00093-9364-01 100 TABLET in 1 BOTTLE (0093-9364-01) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
00093-9364-05 500 TABLET in 1 BOTTLE (0093-9364-05) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
00093-9364-10 1000 TABLET in 1 BOTTLE (0093-9364-10) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
00093-9433-01 100 TABLET in 1 BOTTLE (0093-9433-01) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
00093-9433-05 500 TABLET in 1 BOTTLE (0093-9433-05) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
00093-9477-53 50 TABLET in 1 BOTTLE (0093-9477-53) Glyburide TEVA Pharmaceuticals USA Inc 1984-05-01
23155-0056-01 100 TABLET in 1 BOTTLE (23155-056-01) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
23155-0056-10 1000 TABLET in 1 BOTTLE (23155-056-10) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
23155-0057-01 100 TABLET in 1 BOTTLE (23155-057-01) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
23155-0057-10 1000 TABLET in 1 BOTTLE (23155-057-10) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
23155-0058-01 100 TABLET in 1 BOTTLE (23155-058-01) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
23155-0058-10 1000 TABLET in 1 BOTTLE (23155-058-10) GLYBURIDE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2010-10-05
62135-0583-30 30 TABLET in 1 BOTTLE (62135-583-30) GLYBURIDE Chartwell RX, LLC 2023-05-09
62135-0584-30 30 TABLET in 1 BOTTLE (62135-584-30) GLYBURIDE Chartwell RX, LLC 2023-05-09
62135-0585-90 90 TABLET in 1 BOTTLE (62135-585-90) GLYBURIDE Chartwell RX, LLC 2023-05-09
65841-0832-01 100 TABLET in 1 BOTTLE (65841-832-01) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0832-05 500 TABLET in 1 BOTTLE (65841-832-05) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0832-06 30 TABLET in 1 BOTTLE (65841-832-06) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0832-10 1000 TABLET in 1 BOTTLE (65841-832-10) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0832-16 90 TABLET in 1 BOTTLE (65841-832-16) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0832-77 10 BLISTER PACK in 1 CARTON (65841-832-77) / 10 TABLET in 1... glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-01 100 TABLET in 1 BOTTLE (65841-833-01) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-05 500 TABLET in 1 BOTTLE (65841-833-05) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-06 30 TABLET in 1 BOTTLE (65841-833-06) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-10 1000 TABLET in 1 BOTTLE (65841-833-10) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-16 90 TABLET in 1 BOTTLE (65841-833-16) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0833-77 10 BLISTER PACK in 1 CARTON (65841-833-77) / 10 TABLET in 1... glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-01 100 TABLET in 1 BOTTLE (65841-834-01) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-05 500 TABLET in 1 BOTTLE (65841-834-05) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-06 30 TABLET in 1 BOTTLE (65841-834-06) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-10 1000 TABLET in 1 BOTTLE (65841-834-10) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-16 90 TABLET in 1 BOTTLE (65841-834-16) glyburide Zydus Lifesciences Limited 2016-06-02
65841-0834-77 10 BLISTER PACK in 1 CARTON (65841-834-77) / 10 TABLET in 1... glyburide Zydus Lifesciences Limited 2016-06-02
68382-0656-01 100 TABLET in 1 BOTTLE (68382-656-01) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0656-05 500 TABLET in 1 BOTTLE (68382-656-05) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0656-06 30 TABLET in 1 BOTTLE (68382-656-06) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0656-10 1000 TABLET in 1 BOTTLE (68382-656-10) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0656-16 90 TABLET in 1 BOTTLE (68382-656-16) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0656-77 10 BLISTER PACK in 1 CARTON (68382-656-77) / 10 TABLET in 1... glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0657-01 100 TABLET in 1 BOTTLE (68382-657-01) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
68382-0657-05 500 TABLET in 1 BOTTLE (68382-657-05) glyburide Zydus Pharmaceuticals (USA) Inc. 2016-06-02
Observed labelers: Zydus Lifesciences Limited (18) · Zydus Pharmaceuticals (USA) Inc. (18) · Teva Pharmaceuticals USA, Inc. (9) · Cadila Pharmaceuticals Limited (8) · Modavar Pharmaceuticals LLC (8) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (6) · +3 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.